MD-HAQ

Multidimensional Health Assessment Questionnaire (MDHAQ): what it is and how it’s calculated

The MDHAQ is a streamlined, clinic-friendly patient questionnaire developed as an evolution of the HAQ family to capture function + symptoms + patient global status (and several optional “context” domains) in a format that is feasible in routine care and also usable in trials. It is widely used in rheumatoid arthritis and other rheumatic diseases (including SLE, myositis, scleroderma, etc.) because it yields quantitative indices (especially RAPID3) that correlate well with more complex composite measures but can be completed quickly in waiting rooms and scored in seconds. It is not a disease activity score in the strict mechanistic sense; it is a patient-centered severity and change tool that is particularly valuable for longitudinal monitoring. [1–4]

1) Core MDHAQ components (what patients fill out)

Most MDHAQ versions include:

Physical function (FN) – typically 10 activities (e.g., dressing, getting in/out of bed, walking, grip tasks).

Pain – usually on a 0–10 scale (VAS or NRS).

Patient global assessment (PtGA) – 0–10 scale (overall status).

Optional but common add-ons:

Fatigue (0–10)

Morning stiffness (duration and/or severity)

Sleep quality (0–10)

Mood (anxiety/depression screens)

Review of symptoms (ROS) checklist

Self-reported joint count (RADAI-type items in some versions)

The “core triad” (FN, Pain, PtGA) is the basis of RAPID3, the best-known MDHAQ-derived index. [1–3]

2) How MDHAQ physical function (FN) is calculated

A. Raw function scoring

Each of the 10 function items is usually scored:

0 = without any difficulty

1 = with some difficulty

2 = with much difficulty

3 = unable to do

So the raw FN total ranges 0–30.

B. Convert FN to a 0–10 scale (standard for RAPID3)

To make FN comparable to Pain (0–10) and PtGA (0–10), FN is usually transformed:

(0–10)

(

Raw FN (0–30)

)

FN (0–10)=(

Raw FN (0–30)

)×10

So:

Raw FN 0 → FN 0

Raw FN 15 → FN 5

Raw FN 30 → FN 10

Missing items

Most implementations require a minimum number of completed function items; if a small number are missing, you can prorate:

Raw FN prorated

Sum of answered items

answered

Raw FN prorated=

#answered

Sum of answered items

×10

then convert to 0–30 and then to 0–10 (or directly to 0–10). Practices vary; the key is consistency within your clinic/research workflow.

Important difference from classic HAQ-DI: MDHAQ function scoring is typically more linear and shorter than HAQ-DI and is not always adjusted upward by device/assistance in the same way the classic HAQ-DI is (versions vary). [1,2]

3) How RAPID3 is calculated from MDHAQ

RAPID3 = Routine Assessment of Patient Index Data 3

It uses exactly three patient-reported domains:

FN (0–10, derived from the 10 function items)

Pain (0–10)

PtGA (0–10)

RAPID3

(0–30)

Pain

PtGA

RAPID3 (0–30)=FN+Pain+PtGA

Range: 0 (best) to 30 (worst).

RAPID3 severity categories (commonly used)

A widely used categorization is:

Near remission: ≤ 3

Low severity: >3 to ≤ 6

Moderate severity: >6 to ≤ 12

High severity: > 12 to 30

These cut points have been used extensively in RA and applied broadly in rheumatology practices as practical thresholds for clinical discussion and tracking. [1–3]

4) Other MDHAQ-derived indices you may see

RAPID4

Adds fatigue (0–10):

RAPID4

(0–40)

RAPID3

Fatigue

RAPID4 (0–40)=RAPID3+Fatigue

RAPID5

Often refers to adding another patient domain (commonly self-reported joint count or another symptom score depending on the version used). Because “RAPID5” is not as standardized across all MDHAQ templates, it’s best to specify which MDHAQ form/version you’re using before hard-coding the formula in a workflow. [1,2]

5) What the MDHAQ adds beyond the score (why clinicians like it)

Even when your “official” metric is RAPID3, the MDHAQ form also provides:

a symptom map (ROS) that can flag non-inflammatory drivers of high scores (fibromyalgia features, depression/sleep issues, neuropathic pain patterns),

time-stamped functional trajectory (objective trend),

quick comparison with clinician measures (discordance often reveals hidden problems: mood, deconditioning, osteoarthritis, damage vs inflammation).

This is why MDHAQ is particularly useful for complex systemic diseases: it helps distinguish “ongoing inflammation” from “ongoing impact.” [2–4]

6) What constitutes a meaningful change

MCID varies by disease and baseline severity, but in RA literature:

RAPID3 improvements on the order of ~3–4 points are often clinically noticeable, and larger changes (e.g., >6) typically reflect substantial improvement.

Exact thresholds can vary by context; for research use, anchor-based MCID definitions are preferred. [3,4]

References (AMA)

Pincus T, Sokka T, Kautiainen H. Further development of a physical function scale on a multidimensional health assessment questionnaire (MDHAQ) for routine care of patients with rheumatic diseases. J Rheumatol. 2005;32(8):1432-1439.

Pincus T, Swearingen C, Wolfe F. Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of patient outcomes in routine clinical care. Arthritis Rheum. 1999;42(10):2220-2230.

Pincus T, Yazici Y, Bergman MJ. RAPID3, an index of patient-reported outcomes, can be used to assess clinical status in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2008;59(6):900-908.

Shaver TS, Anderson JD, Weidensaul DN, et al. The minimally important difference for the Routine Assessment of Patient Index Data 3 (RAPID3) in rheumatoid arthritis. J Rheumatol. 2012;39(11):2017-2023.

Multidimensional Health Assessment Questionnaire (MDHAQ): what it is and how it’s calculated

1) Core MDHAQ components (what patients fill out)

Most MDHAQ versions include:

Physical function (FN) – typically 10 activities (e.g., dressing, getting in/out of bed, walking, grip tasks).

Pain – usually on a 0–10 scale (VAS or NRS).

Patient global assessment (PtGA) – 0–10 scale (overall status).

Optional but common add-ons:

Fatigue (0–10)

Morning stiffness (duration and/or severity)

Sleep quality (0–10)

Mood (anxiety/depression screens)

Review of symptoms (ROS) checklist

Self-reported joint count (RADAI-type items in some versions)

The “core triad” (FN, Pain, PtGA) is the basis of RAPID3, the best-known MDHAQ-derived index. [1–3]

2) How MDHAQ physical function (FN) is calculated

A. Raw function scoring

Each of the 10 function items is usually scored:

0 = without any difficulty

1 = with some difficulty

2 = with much difficulty

3 = unable to do

So the raw FN total ranges 0–30.

B. Convert FN to a 0–10 scale (standard for RAPID3)

To make FN comparable to Pain (0–10) and PtGA (0–10), FN is usually transformed:

(0–10)

(

Raw FN (0–30)

)

FN (0–10)=(

Raw FN (0–30)

)×10

So:

Raw FN 0 → FN 0

Raw FN 15 → FN 5

Raw FN 30 → FN 10

Missing items

Most implementations require a minimum number of completed function items; if a small number are missing, you can prorate:

Raw FN prorated

Sum of answered items

answered

Raw FN prorated=

#answered

Sum of answered items

×10

then convert to 0–30 and then to 0–10 (or directly to 0–10). Practices vary; the key is consistency within your clinic/research workflow.

3) How RAPID3 is calculated from MDHAQ

RAPID3 = Routine Assessment of Patient Index Data 3

It uses exactly three patient-reported domains:

FN (0–10, derived from the 10 function items)

Pain (0–10)

PtGA (0–10)

RAPID3

(0–30)

Pain

PtGA

RAPID3 (0–30)=FN+Pain+PtGA

Range: 0 (best) to 30 (worst).

RAPID3 severity categories (commonly used)

A widely used categorization is:

Near remission: ≤ 3

Low severity: >3 to ≤ 6

Moderate severity: >6 to ≤ 12

High severity: > 12 to 30

These cut points have been used extensively in RA and applied broadly in rheumatology practices as practical thresholds for clinical discussion and tracking. [1–3]

4) Other MDHAQ-derived indices you may see

RAPID4

Adds fatigue (0–10):

RAPID4

(0–40)

RAPID3

Fatigue

RAPID4 (0–40)=RAPID3+Fatigue

RAPID5

5) What the MDHAQ adds beyond the score (why clinicians like it)

Even when your “official” metric is RAPID3, the MDHAQ form also provides:

a symptom map (ROS) that can flag non-inflammatory drivers of high scores (fibromyalgia features, depression/sleep issues, neuropathic pain patterns),

time-stamped functional trajectory (objective trend),

quick comparison with clinician measures (discordance often reveals hidden problems: mood, deconditioning, osteoarthritis, damage vs inflammation).

This is why MDHAQ is particularly useful for complex systemic diseases: it helps distinguish “ongoing inflammation” from “ongoing impact.” [2–4]

6) What constitutes a meaningful change

MCID varies by disease and baseline severity, but in RA literature:

RAPID3 improvements on the order of ~3–4 points are often clinically noticeable, and larger changes (e.g., >6) typically reflect substantial improvement.

Exact thresholds can vary by context; for research use, anchor-based MCID definitions are preferred. [3,4]

References (AMA)

Pincus T, Swearingen C, Wolfe F. Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of patient outcomes in routine clinical care. Arthritis Rheum. 1999;42(10):2220-2230.

Pincus T, Yazici Y, Bergman MJ. RAPID3, an index of patient-reported outcomes, can be used to assess clinical status in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2008;59(6):900-908.